These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2106401

  • 1. Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.
    Gottlieb SS, Kukin ML, Medina N, Yushak M, Packer M.
    Circulation; 1990 Mar; 81(3):860-4. PubMed ID: 2106401
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure.
    Gottlieb SS, Kukin ML, Yushak M, Medina N, Packer M.
    Ann Intern Med; 1989 Apr 01; 110(7):505-9. PubMed ID: 2493762
    [Abstract] [Full Text] [Related]

  • 4. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL, Sze DY, Keefe DL, Swerdlow CD, Echt DS, Griffin JC, Winkle RA, Mason JW.
    Circulation; 1982 Dec 01; 66(6):1205-10. PubMed ID: 6814784
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW, Hammill SC.
    Mayo Clin Proc; 1987 Nov 01; 62(11):1033-50. PubMed ID: 3118116
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemodynamic effects of antiarrhythmic drugs.
    Block PJ, Winkle RA.
    Am J Cardiol; 1983 Sep 22; 52(6):14C-23C. PubMed ID: 6414278
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR.
    Drug Intell Clin Pharm; 1985 Sep 22; 19(7-8):514-7. PubMed ID: 3928308
    [Abstract] [Full Text] [Related]

  • 13. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF, Morganroth J.
    Compr Ther; 1987 Apr 22; 13(4):26-35. PubMed ID: 3105950
    [Abstract] [Full Text] [Related]

  • 14. Antiarrhythmic drugs.
    Roy D.
    Can Anaesth Soc J; 1986 May 22; 33(3 Pt 2):S65-7. PubMed ID: 2872953
    [No Abstract] [Full Text] [Related]

  • 15. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent.
    Morganroth J, Nestico PF, Horowitz LN.
    Am Heart J; 1985 Oct 22; 110(4):856-63. PubMed ID: 3931446
    [Abstract] [Full Text] [Related]

  • 16. The clinical pharmacology of lidocaine congeners--review of encainide, flecainide, lorcainide and tocainide.
    McDevitt DG.
    Eur Heart J; 1984 Sep 22; 5 Suppl B():63-6. PubMed ID: 6437818
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventricular function.
    Sami MH, Derbekyan VA, Lisbona R.
    Am J Cardiol; 1983 Sep 01; 52(5):507-11. PubMed ID: 6412535
    [Abstract] [Full Text] [Related]

  • 18. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide].
    Halawa B.
    Pol Tyg Lek; 1983 Sep 01; 45(10-11):222-4. PubMed ID: 2120685
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ.
    Eur Heart J; 1984 Sep 01; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.